Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5907_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
194
Nano Physical Pharmaceutics of Nanogel Delivery System
38. He L, Li D, Wang Z, Xu W, Wang J, Guo H, Wang C, Ding J, 2016, , 36.
8
39.
SV, Bronich TK, Kabanov AV,
Adv
Drug , Deliv Rev
Polymers
2002, 54,
135–147.
Macromol Biosci
Huynh L, Neale C, Pomès R, Allen C, Swope
Comput
AC, Parker AJ, Sly J, Miller
, 3733–3749.
2017
Soft Matter
RD,
1700092.
17,
, 6.
2010
Rice JE,
J Chem Theory
 
Appel EA, Nguyen T, Piunova V, , , 255–261. Carr
AC, Piunova VA, Maarof H, Rice
122
, 5356–5367.
Adv Drug Deliv Rev
T, Liu Zhou L, Y,
H, Wu Z, Chen
M, Wu T,
47.
Adroher-Benítez I, Ahualli S, Moncho-Jordá A,
48.
Adroher-Benítez Odriozola
Mater Sci Eng C Mater Biol Appl
Macromolecules 2015
I, Martín-Molina
G, Moncho-Jordá
Polymer
JE, Swope
T, Liang
A,
A, Phys
2015
79
WC,
J Phys Chem B 2018
65
2013
Ke B,
2014,
, 36–48.
Huang
43
, 622–629.
H, Jiang Z, Xie
A, Quesada-Pérez M,
, , 4645–4656.
48
Ahualli S, Quesada-Pérez
Chem
Phys 2017, 19
Chem ,
M,
6838–6848.
JC, Blanco
M,
J Control Release
YK, Kim EJ, Lim JH,
Res Lett 2019
CM, Doyle
, ,
ERO, Gugliotta
2019 307
Cho Hong
14
Int J Pharm
FJ, Peppas
LM, Alvarez Igarzabal CI, Calderon
, , 221–246.
Gels
2017, 3, 16.
2003
WJ,
266
NA,
Macromolecules
HK, Jeon HH, Chung BG,
Nanoscale
1997 30
6166–6173.
Tang M, Bowyer
A, Eisenthal R,
Hubble J,
React Funct Polym
2006, 66, 757–767.
Biosens Bioelectron
56. Alvarez-Lorenzo C, Bromberg L, Concheiro
, , 848–860.
2009
Wu
W, 85Shen J, Banerjee P, Zhou S, , ,
2003,
18, 1289–1297.
A,
Photochem Photobiol
Adv
Funct Mater 2011 21
2830–2839.
K, Huang J, Ding G, Chen J, Liu
Y,
J Drug Target 2006, 14,
243–253.
,
References
195
59. Wu W, Shen J, Gai Z, Hong K, Banerjee P, Zhou S, Biomaterials 2011, 32, 9876–9887.
60. Purushotham S, Chang PE, Rumpel H, Kee IH, Ng RT, Chow PK, Tan CK, Ramanujan RV, Nanotechnology 2009, 20, 305101.
61. Quan CY, Wei H, Sun YX, Cheng SX, Shen K, Gu ZW, Zhang XZ, Zhuo RX, J Nanosci Nanotechnol 2008, 8, 2377–2384.
62. Fan T, Li M, Wu X, Li M, Wu Y, Colloids Surf B Biointerfaces 2011, 88, 593–600.
63. Liu C, Yang L, Qiao L, Liu C, Zhang M, Jian X, Polym Int 2019, 68, 1102–1112.
64. Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Kim S W, Junzo S, J Controlled Release 1998, 54, 313–320.
Chapter 6
Nano Physical Pharmaceutics of Microsphere Delivery System
Zhiwen Qiu,
a
Wanru Tao,a Man Wang,a Hanwen Sun,b and Wei Li
a
a
Department of Nanomedicine, Naval Medical University,
Shanghai 200433, China
b
College of Medicine and Nursing, Dezhou University,
Shandong 253023, China
liwei_dds@163.com

6.1 Classification of Microspheres

Microspheres refer to tiny spherical entities formed during the dissolution or dispersion of drugs in a matrix of polymer materials and shall be categorized as matrix-type skeleton particles [1].
                       
as nanospheres or nanoparticles, which belong to the colloid category [1]. After being made into microspheres, drugs can
               
reducing the number of administrations, and improving the
       
Nano Physical Pharmaceutics
Edited by Wei Li Copyright © 2025 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-52-2 (Hardcover), 978-1-003-51393-3 (eBook)
www.jennystanford.com
198
Nano Physical Pharmaceucs of Microsphere Delivery System
such as improving the stability of the drug, preventing the inactivation of drugs in the stomach or reducing the irritation to the stomach, facilitating the application and storage of liquid drugs, and realizing the sustained release of drugs. With the development of new technologies, the new process and new materials, long-acting biodegradable injection microspheres have become one of the important research areas of new pharmaceutical preparations [2, 3].
According to the synthesized materials, they can be divided into natural polymer microspheres, semi-synthetic polymer microspheres and synthetic polymer microspheres. The natural polymers used include carbohydrates (glucan, starch, chitin and chitosan), acacia gum, alginate, protein (hyaluronic acid, gelatin
         
types of substances, which are generally degradable in vivo and safe. The semi-synthetic polymers contain carboxymethyl cellulose salts, methyl cellulose, ethyl cellulose, etc., which have low toxicity, high viscosity and increased solubility after the salt formation. However, due to hydrolyze, they cannot be processed at high temperatures and need to be prepared as they are used. The new biodegradable polymers in synthetic polymers have become an important carrier of microsphere preparations, among which polylactic acid (PLA), polyglycolic acid (PGA), polylactic-co-glycolic acid (PLGA), polylactic acid and polyethylene glycol segmented copolymer (PLA-PEG), e-caprolactone and lactide segmented copolymer, polycarbonate, etc. are commonly used, which have
        
forming and sphere-forming properties [4–6].
Based on the structures of microspheres, they can be divided into solid microspheres with the entire microspheres as a dense structure, hollow microspheres with a hollow interior, and porous microspheres with multiple holes on the surface. Compared with the other two, hollow microspheres have unique advantages in the controlled release and sustained release of drugs. However, the preparation is currently only in the experimental research stage due to the complicated preparation method and high cost,
          
their bright application prospects. Biodegradable polymer porous

Preparation of Microspheres

199
microspheres can be degraded in vivo     thus having been widely applied in controlled drug release, tissue

6.2 Preparation of Microspheres
The selection of microspheres carriers shall generally put the following factors into consideration: stable in nature, non-toxic and non-irritating properties, certain strength, elasticity and plasticity, the ability to completely wrap drugs and achieve a reasonable release speed, and the fact that after compounding
                 
process of microspheres is exhibited in Fig. 6.1.
             
phase separation method, solvent evaporation method, spray drying method, salting-out method, ultrasonic method, supercritical
 
used in the preparation of microspheres with various structures are listed below.
Figure 6.1 Schematic diagram of preparation of drug-loaded microspheres.

6.2.1 Emulsification: Chemical Cross-Linking Method

    
mixing the drug with the carrier solution and dispersing it in an immiscible medium to form a similar water-in-oil or oil-in-water type emulsion, and then forming microspheres by cross-linking. This method involves the cross-linking of groups in polymer materials with the participation of cross-linking agents (such as formaldehyde and glutaraldehyde) to form microspheres, which generally uses the amino groups in the material to condense
200
Nano Physical Pharmaceucs of Microsphere Delivery System
with the aldehyde group in the cross-linking agent to solidify microspheres [11].
Compared with the traditional solvent evaporation technology and spray drying technology, the microspheres prepared by
      
structure and a more ideal drug loading capacity. Whereas, microspheres prepared by the traditional method have a low
 
fact that drugs can only be adsorbed on the surface of microspheres,
           
nature of materials, the synthesis concentration, pH value of
         
Among them, the concentration ratio of the materials and the drugs is the main factor that determines the drug encapsulation


6.2.2 Solvent Evaporation

          
(such as organic solvents like methylene chloride, chloroform or ethyl acetate) containing carrier material and water insoluble
             
(W/O) or water-in-oil-in-water (W/O/W) emulsion. The organic solvents in the emulsion are removed by evaporation using elevated temperature, reduced pressure extraction or continuous stirring, and then prepared into drug microspheres by washing, centrifugation and freeze-drying. Cellulose derivatives, polyesters and polymeric anhydrides can be used as materials for the liquid drying method [13, 14].
The evaporation method is simple to operate and suitable
  
This program is usually divided into single the emulsion method and the re-emulsion method, of which the latter is more widely used. The single emulsion method can be divided into O/W and O/O types. The former is suitable for fat-soluble drugs. Under the same circumstances, the encapsulation rate of water-soluble drugs is low, but it can be relatively improved by methods such
Preparation of Microspheres
201
as pre-emulsifying the water with the drug to saturate the water phase. The re-emulsion method is often used to prepare water-soluble drug microspheres. Generally, polymers are dissolved in methylene chloride, chloroform and other organic solvents, and then an aqueous solution of drugs or active
       
After that, they are dispersed in the outer aqueous phase and form the W/O/W type double emulsion to solidify microspheres with


6.2.3 Phase Separation

Phase separation is a widely used method for preparing microspheres. Its main principle is to dissolve polymer materials
         
the materials in the two solutions to obtain microspheres by
      
were optimized by adjusting and controlling the temperature, pH value in the preparation process, as well as adding poor solvents and polymers causing phase separation. The equipment required is simple, together with a wide range of polymer materials, making it suitable for various types of drug microencapsulation. However, problems such as microcapsules or microspheres adhesion, and aggregation are quite common (which is more serious in the gelatin hydrophilic system) [13].

6.2.4 Salting-Out Method

         
caused by the addition of a large amount of neutral salt, i.e., most or all of the free water in the original solution is transformed
 
molecules forced into contact with the hydrophobic groups on the surface of materials to mask them become free water molecules for further use (not the water molecules involved in the solvation of the polar groups on the protein surface. Instead, they are bound by electrostatic interaction, the link is much stronger than those water molecules in contact with hydrophobic groups), so they are removed to solvate the salt ion, leaving the exposed
202
Nano Physical Pharmaceucs of Microsphere Delivery System
hydrophobic group. As the salt concentration increases, the hydrophobic surface of the material is further exposed, and the material aggregates and precipitates due to hydrophobic interaction. The method of salting out uses the principle of reversible expansion of polymer materials in solvents [18]. When the polymer materials expand, drugs are added, then the pH is adjusted, and the salting-out agent is added to precipitate the polymer materials and drugs. After centrifugation and drying, microspheres that carry drugs can be obtained. This method of preparing drug-loading microspheres is relatively simple and does not require special equipment. However, the disadvantage of this method is that the concentration of the carrier material during the preparation of microspheres cannot be too high; otherwise, the salting-out agent cannot be evenly distributed, which will easily cause the material to aggregate and form large clusters. Since the drug is bound to the surface of microspheres by adsorption, the extent of sustained drug release is also very limited. In addition, the surface charge balance of microspheres is easy to break when the pH changes in vivo, which changes the solubility of microspheres and further accelerates the release of drugs.

6.2.5 Spray Drying

Spray drying involves dispersing drugs in the solution of the materials, and then spraying the mixture into the hot air stream
             
uses material drug suspension rheology and the nozzle design to control the size and shape of microspheres. Compared with other methods, this method requires short time, and is featured with simple production process, easy operation and control, high product purity, and good dispersibility. However, special
        
of microspheres are more complicated, including: the viscosity of the mixed liquid, the uniformity, the concentration of drugs and materials, the spray rate, the spray method and the hot air temperature [13, 21, 22]. Spray drying has been applied to natural polymer materials such as albumin and chitosan.
Preparation of Microspheres
203
Compared with the solvent evaporation method, this method
       
and the long-term contact between the drug and the organic
        
samples, and opens up a new way for the preparation of unstable drug microspheres. In addition, due to the rapid volatilization of the solvent during the drying process, the temperature of the droplets can be kept lower than that of the drying air, thus facilitating the preparation of temperature-sensitive drugs.

6.2.6 Ultrasound Method

Air albumin microspheres for acoustic contrast can be prepared by using ultrasonic energy to heat the albumin solution to a temperature close to denaturation, which will cause “cavitation” of the micro air originally present in the solution and the air brought in from outside. Under the action of sound waves, the existing bubbles in the liquid expand and then burst to generate a large number of microbubbles [13, 21]. These microbubbles undergo further cavitation under the action of sound waves, thereby splitting to generate more microbubbles. The cavitation process is controlled by controlling the ultrasonic energy and sound
        
microspheres with good uniformity to meet the needs [23].

6.2.7 Supercritical Fluid Method

In the foregoing methods, a large amount of organic solvents are used, and post-treatments such as washing and drying are required,
         
product quality [13, 24]. At present, the phase separation technology
      
system has been used in the preparation of microspheres. The system mainly includes rapid expansion of supercritical solution (RESS), gas anti-solvent recrystallization (GAS) and precipitation
 
meet the requirements of light-proof, air-isolated, waterproof, sterile, etc., thus enabling production expansion [13].